Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FENC stock hub

Fennec Pharmaceuticals Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FENCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

240.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

FENC

In the news

Latest news · FENC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E55.9

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-65.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-16

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FENC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001211583
Company name	Fennec Pharmaceuticals Inc.
Country	United States
Country code	US
Cusip	31447P100
Employees	35
Employees Change	3%
Employees Change Percent	9.38
Enterprise value	$203.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2001-06-05
Isin	CA31447P1009
Last refreshed	2026-05-10
Market cap	$240.6M
Market cap category	Micro-Cap
Price	$6.93
Price currency	USD
Rev Per Employee	1,275,485.71x
Sector	Healthcare
Sic	2836
Symbol	FENC
Website	https://www.fennecpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.05%
EV Sales Forward	2.88x
EV/Sales	4.56x
Forward P/E	55.89x
P/B ratio	6.67x
P/S ratio	5.39x
PS Forward	3.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-14.07%
EBITDA Margin	-13.84%
Gross margin	91.57%
Gross Profit	$40.9M
Gross Profit Growth	-7.84%
Gross Profit Growth Q	65.56%
Gross Profit Growth3 Y	204.42%
Gross Profit Growth5 Y	199.37%
Net Income	$-9.7M
Net Income Growth Years	0%
Pretax Margin	-21.58%
Profit Margin	-21.82%
Profit Per Employee	$-278,314
ROA	-6.8
Roa5y	-25.84
ROCE	-10.46
ROE	-65.82
ROIC	-16.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.38%
Cagr15y	8.08%
Cagr1y	13.43%
Cagr20y	-8.74%
Cagr3y	-5.42%
Cagr5y	2.35%
EPS Growth Years	0
Revenue Growth	-6.09x
Revenue Growth Q	73.84x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	207.52x
Revenue Growth5 Y	204.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.77
Assets	$70.6M
Cash	$36.8M
Current Assets	$67M
Current Liabilities	$10.5M
Equity	$35.5M
Interest Coverage	-2.93
Liabilities	$35.1M
Long Term Assets	$3.5M
Long Term Liabilities	$24.6M
Net Cash	$36.8M
Net Cash By Market Cap	$15.29
Net Cash Growth	404.36%
Net Debt Equity	$-1.04
Tangible Book Value	$35.5M
Tangible Book Value Per Share	$1.04
WACC	9.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.37
Inventory Turnover	2.87
Net Working Capital	$19.7M
Quick ratio	5.71
Working Capital	$56.5M
Working Capital Turnover	$0.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	193.64%
1Y total return	13.42%
200-day SMA	7.94
3Y total return	-15.38%
50-day SMA	6.92
50-day SMA vs 200-day SMA	50under200
5Y total return	12.32%
All Time High	124.2
All Time High Change	-94.42%
All Time High Date	2004-11-24
All Time Low	0.29
All Time Low Change	2,314.63%
All Time Low Date	2015-11-27
ATR	0.39
Beta	0.91
Beta1y	1.94
Beta2y	1.42
Ch YTD	-10
High	7.25
High52	9.92
High52 Date	2025-10-06
High52ch	-30.14%
Low	6.9
Low52	5.65
Low52 Date	2026-04-13
Low52ch	22.66%
Ma50ch	0.19%
Premarket Change Percent	-2.9
Premarket Price	$6.7
Premarket Volume	2,800
Price vs 200-day SMA	-12.73%
RSI	53.86
RSI Monthly	47.29
RSI Weekly	45.21
Sharpe ratio	0.43x
Sortino ratio	0.73
Total Return	-4.7%
Tr YTD	-10
Tr15y	220.83%
Tr1m	9.65%
Tr1w	5.96%
Tr3m	-11.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$15
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	13,862,080x
Earnings Revenue Estimate Growth	58.41x
Operating Income	$-6.3M
Operating margin	-14.07
Price target	$14.5
Price Target Change	$109
Price Target Change Top	$116

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,077,994%
Float Percent	49.2%
Net Borrowing	-19,477,000
Shares Insiders	3.26%
Shares Institutions	17.53%
Shares Out	34,712,756
Shares Qo Q	11.78%
Shares Yo Y	4.7%
Short Float	5.45%
Short Ratio	3.72
Short Shares	2.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	142,306x
Bv Per Share	1.04
Ch10y	193.6
Ch15y	220.8
Ch1m	9.65
Ch1w	5.96
Ch1y	13.42
Ch20y	-83.96
Ch3m	-11.61
Ch3y	-15.38
Ch5y	12.32
Ch6m	-13.16
Change	0.43%
Change From Open	-0.14
Close	6.9
Days Gap	0.58
Depreciation Amortization	102,667
Dollar Volume	1,462,528
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-6.3M
EBITDA	$-6.2M
EPS	$-0.34
F Score	0
Financing CF	22,627,000
Fiscal Year End	December
Founded	1,996
Income Tax	$106,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Last Split Date	2014-09-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	7.69
Ma150ch	-9.91%
Ma20	6.62
Ma20ch	4.65%
Net CF	10,154,000
Next Earnings Date	2026-05-14
Open	6.94
Optionable	Yes
Position In Range	8.57
Post Close	6.93
Postmarket Change Percent	1.88
Postmarket Price	$7.06
Pre Close	6.9
Price Date	2026-05-08
Ptbv Ratio	6.78
Relative Volume	1.48x
Revenue	44,642,000x
SBC By Revenue	15.75x
Share Based Comp	7,033,000
Tax By Revenue	0.24x
Tr20y	-83.96%
Tr6m	-13.16%
Us State	North Carolina
Volume	211,043
Z Score	0.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FENC pay a dividend?

Capital-return profile for this ticker.

Performance

FENC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FENC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.5%

Float: +49.2% of shares outstanding

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FENC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.9

Neutral momentum band

Price vs 200-day MA

-12.7%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FENC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current FENC stock rating?

Fennec Pharmaceuticals Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full FENC analysis?

The full report lives at /stocks/FENC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for FENC?

The latest report frames FENC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the FENC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.